BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34405216)

  • 21. The β3 subunit contributes to vascular calcium channel upregulation and hypertension in angiotensin II-infused C57BL/6 mice.
    Kharade SV; Sonkusare SK; Srivastava AK; Thakali KM; Fletcher TW; Rhee SW; Rusch NJ
    Hypertension; 2013 Jan; 61(1):137-42. PubMed ID: 23129698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
    Yang C; Wu X; Shen Y; Liu C; Kong X; Li P
    Eur J Pharmacol; 2020 Sep; 883():173384. PubMed ID: 32707188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
    Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
    J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
    Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
    Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microsomal prostaglandin synthase-1-derived prostaglandin E2 protects against angiotensin II-induced hypertension via inhibition of oxidative stress.
    Jia Z; Guo X; Zhang H; Wang MH; Dong Z; Yang T
    Hypertension; 2008 Nov; 52(5):952-9. PubMed ID: 18824665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
    Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension.
    Wakui H; Dejima T; Tamura K; Uneda K; Azuma K; Maeda A; Ohsawa M; Kanaoka T; Azushima K; Kobayashi R; Matsuda M; Yamashita A; Umemura S
    Cardiovasc Res; 2013 Dec; 100(3):511-9. PubMed ID: 24189624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natriuretic peptide receptor-C activation attenuates angiotensin II-induced enhanced oxidative stress and hyperproliferation of aortic vascular smooth muscle cells.
    Madiraju P; Hossain E; Anand-Srivastava MB
    Mol Cell Biochem; 2018 Nov; 448(1-2):77-89. PubMed ID: 29417337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice.
    Jacobi J; Maas R; Cordasic N; Koch K; Schmieder RE; Böger RH; Hilgers KF
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H1058-66. PubMed ID: 18156199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. iPLA2β overexpression in smooth muscle exacerbates angiotensin II-induced hypertension and vascular remodeling.
    Calderon LE; Liu S; Su W; Xie Z; Guo Z; Eberhard W; Gong MC
    PLoS One; 2012; 7(2):e31850. PubMed ID: 22363752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
    Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
    Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Qingda granule inhibits angiotensin Ⅱ induced VSMCs proliferation through MAPK and PI3K/AKT pathways.
    Yu N; Shen A; Chu J; Huang Y; Zhang L; Lin S; Cai Q; Sankararaman S; Sferra TJ; Chen Y; Peng J
    J Ethnopharmacol; 2020 Aug; 258():112767. PubMed ID: 32199989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity.
    Li FF; Shang XK; Du XL; Chen S
    Curr Med Sci; 2018 Feb; 38(1):93-100. PubMed ID: 30074157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
    Han YJ; Hu WY; Piano M; de Lanerolle P
    Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heme oxygenase-1 in vascular smooth muscle cells counteracts cardiovascular damage induced by angiotensin II.
    Morita T; Imai T; Sugiyama T; Katayama S; Yoshino G
    Curr Neurovasc Res; 2005 Apr; 2(2):113-20. PubMed ID: 16181103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage.
    Shen M; Morton J; Davidge ST; Kassiri Z
    J Mol Cell Cardiol; 2017 Feb; 103():11-21. PubMed ID: 27993561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostacyclin induces apoptosis of vascular smooth muscle cells by a cAMP-mediated inhibition of extracellular signal-regulated kinase activity and can counteract the mitogenic activity of endothelin-1 or basic fibroblast growth factor.
    Li RC; Cindrova-Davies T; Skepper JN; Sellers LA
    Circ Res; 2004 Apr; 94(6):759-67. PubMed ID: 14963006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α7 Nicotinic Acetylcholine Receptor Relieves Angiotensin II-Induced Senescence in Vascular Smooth Muscle Cells by Raising Nicotinamide Adenine Dinucleotide-Dependent SIRT1 Activity.
    Li DJ; Huang F; Ni M; Fu H; Zhang LS; Shen FM
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1566-76. PubMed ID: 27339462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle.
    Weber DS; Rocic P; Mellis AM; Laude K; Lyle AN; Harrison DG; Griendling KK
    Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H37-42. PubMed ID: 15345488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
    Chan SL; Umesalma S; Baumbach GL
    Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.